---
slug: 'novo-nordisk-dcf-valuation'
date: '11/29/2025'
title: 'NVO: Novo Nordisk Valuation: A discounted cash flow approach'
subtitle: 'Novo Nordisk went from breifly being the largest European company by market cap to declining 60% or more in less than 6 months. A century-old enterprise, NVO is investing heavily by acquisitons, CapEX, and  R&D. NVO's online prescription delivery business and international revenue segmant is showing impressive growth. Let's analyze Novo Nordisk's fundamental and conduct an intrinsic valuation of the company.'
categories:
  ['NVO', 'Novo Nordisk', 'Denmark', 'DCF Valuation', 'Signals', 'Valuation']
image: 'https://upload.wikimedia.org/wikipedia/commons/e/e6/Monnaie_de_Bactriane%2C_Eucratide_I%2C_2_faces.jpg'
author: 'Kanchan'
---
